Clinical Study

A Phase 3, Open-Label, 1-Year Study Of The Safety, Tolerability, And Need For Re-Treatment With Sage-217 In Adult Subjects With Major Depressive Disorder

Posted Date: Jan 25, 2021

  • Investigator: Caleb Adler
  • Specialties: Depression, Psychiatry/Psychology
  • Type of Study: Drug

This study is to determine the safety and tolerability of initial treatment and/or re-treatment(s) in adults with MDD experiencing a major depressive episode (MDE) .


Adults With Mdd Experiencing A Major Depressive Episode.


Depression, Mdd, Adults

For More Information:

Emily Rummelhoff